Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results.
Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.
GAAP net earnings rose nearly 70% YoY to $2 billion and EPS rose nearly 73% to $1.14. Adjusted EPS grew 22.2% to $1.43.
For FY2022, GAAP EPS is expected to be at least $3.50 and adjusted EPS is expected to be at least $4.90.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Omnichannel push, margin dynamics in focus as Walmart gears up for Q3 earnings
Walmart Inc. (NYSE: WMT) entered the second half of FY26 navigating a challenging retail landscape marked by tariff-related cost pressure and cautious consumer behavior. At the same time, the company
AMAT Earnings: Applied Materials Q4 adjusted profit drops on lower revenues
Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported a decrease in adjusted earnings for the fourth quarter of fiscal 2025. Adjusted earnings declined to $2.17 per share
Disney’s (DIS) streaming business continues its momentum in Q4 2025
Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter of 2025. While earnings beat expectations, revenues fell
